UK's Assura agrees to $2.06 billion takeover by KKR-Stonepeak
UK's Assura agrees to $2.06 billion takeover by KKR-Stonepeak
Source link
Similar Posts
Here’s The Average TFSA Balance at Age 44 in Canada
Have you ever wondered whether your tax-free savings account (TFSA) is up to par with TFSAs held by others your age? It may seem like a ‘vanity metric,’ but knowing where you stand in the savings game compared with your peers is a valuable thing. Among other things, it provides you with motivation to continue…
MaxLinear (NASDAQ:MXL) Posts Earnings Results, Hits Estimates
MaxLinear (NASDAQ:MXL – Get Free Report) issued its quarterly earnings data on Wednesday. The semiconductor company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.12). MaxLinear had a negative net margin of 61.63% and a negative return on equity of 21.86%. Source link
Oblong Stock Back on Track! Nasdaq Compliance Restored – What’s the Forecast? 🔮
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, will adversely affect certain features and functions. The technical storage or access is strictly…
NUZ – Neurizon Therapeutics Limited
14th January 2019 – Perth, Australia: PharmAust Limited (ASX: PAA), a clinical stage oncology company that is engaged in collaboration with the Olivia Newton-John Cancer Research Institute (ONJCRI), is pleased to announce important findings confirming anti-cancer activity of monepantel’s major metabolite, monepantel sulfone. The human cancer cell lines tested were representative of cancers that PharmAust…
